| dc.contributor.author | Berenguer Berenguer, Juan | |
| dc.contributor.author | González García, Juan | |
| dc.contributor.author | Ribera Pascuet, Esteban | |
| dc.contributor.author | Domingo Pedrol, Pere | |
| dc.contributor.author | Santos González, Jesús | |
| dc.contributor.author | Miralles Martín, Pilar | |
| dc.contributor.author | Ribas del Blanco, María Ángeles | |
| dc.contributor.author | Asensi Álvarez, Víctor | |
| dc.contributor.author | Gimeno-Bayón Cobos, Juan Luis | |
| dc.contributor.author | Pérez Molina, José Antonio | |
| dc.contributor.author | Terrón Pernía, José Alberto | |
| dc.contributor.author | Santamaría Jáuregui, Juan Miguel | |
| dc.contributor.author | Pedrol Clotet, Enric | |
| dc.date.accessioned | 2013-01-30T10:24:00Z | |
| dc.date.available | 2013-01-30T10:24:00Z | |
| dc.date.issued | 2008 | |
| dc.identifier.citation | Clinical Infectious Diseases, 47(8), p. 1083-1092 (2008); doi:10.1086/592114 | spa |
| dc.identifier.issn | 1058-4838 | |
| dc.identifier.issn | 1537-6591 | |
| dc.identifier.uri | http://hdl.handle.net/10651/11349 | |
| dc.format.extent | p. 1083-1092 | spa |
| dc.language.iso | eng | |
| dc.relation.ispartof | Clinical Infectious Diseases | spa |
| dc.rights | (c) Clinical Infectious Diseases | |
| dc.source | WOK | spa |
| dc.title | Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of HIV type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903 | spa |
| dc.type | journal article | |
| dc.identifier.local | 227 | spa |
| dc.identifier.doi | 10.1086/592114 | |
| dc.relation.publisherversion | http://dx.doi.org/10.1086/592114 | spa |
